Researchers have developed a new method for detecting H. pylori and its mutations in dyspeptic patients, which could be a ...

The Helicobacter pylori Genome Project:  insights into H. pylori population structure from analysis of a worldwide collection ...

CRISPR-based test FELUDA detects H. pylori, the bacteria linked to ulcers and gastric cancer, advancing diagnostic precision.

The Global Helicobacter Pylori Diagnostics Market, valued at approximately USD 601.2 million in 2022, is projected to grow at a robust CAGR of more than 6% during the forecast period from 2023 to 2030 ...

Expert Rev Anti Infect Ther. 2007;5(5):845-856. Even if the prevalence of H. pylori infection increases in elderly patients who are institutionalized, the 'search and treat' approach is not ...

Addition of metronidazole to rabeprazole–amoxicillin–clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy. Helicobacter 5, 88–93 (2000).

Background and Aim: Common endoscopic findings in stomachs with Helicobacter pylori infections include antral nodularity, thickened gastric folds, and visible submucosal vessels. These findings ...

IGIB and AIIMS develop a CRISPR-based FELUDA test for detecting H. pylori using en31-FnCas9 tech, aiding rural diagnostics.

Stomach ulcers, caused by H. pylori infection, can lead to painful symptoms. Diagnosis includes breath, stool, blood tests, and treatment involves antibiotics, PPIs, and dietary changes.

Drs. Barry Marshall and Robin Warren shared the 2005 Nobel Prize in medicine for their discovery of Helicobacter pylori and their additional finding that H. pylori is the cause of stomach ulcers.

Addressing poor management of a preventable cause of gastric cancer will lead to better outcomes and improve equity and ...